Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Nucleus RadioPharma Plans Rochester, Minnesota, Radiopharmaceuticals Production Campus

05/12/2023
Nucleus RadioPharma, a radiopharmaceutical company, plans to establish operations in Rochester, Minnesota. The project is expected to create 28 jobs within the first two years.

The investment includes 6,500-square-feet of laboratory and manufacturing as well as an additional 3,500-square-feet of office space at the Two Discovery Square building, within Destination Medical Center's Discovery Square District. Operations are scheduled for mid-2024.

"The endorsement from the City of Rochester and DEED strongly positions us to solve a complex challenge in health care and deepen our collaboration with Mayo Clinic to provide critical access to care for patients," says Charles Conroy, CEO of Nucleus.

The project received approval from the Minnesota Department of Employment and Economic Development for an economic incentive request.

"This developmental milestone reinforces Mayo Clinic's aim of ensuring that patients have access to advanced cancer clinical trials and cutting-edge treatments," noted Geoff Johnson, M.D., Ph.D., associate medical director of Radiology at Mayo Clinic Comprehensive Cancer Center. "Mayo Clinic continues to make significant strides within emerging industries like that of radiopharmaceuticals to create the most sophisticated and innovative ecosystem for the development and delivery of solutions for patients everywhere."

Founded by Eclipse Ventures and Mayo Clinic, Nucleus RadioPharma is a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new treatment tools.

"It's truly an exciting time in health care, as we reimagine how we treat patients and develop the next generation of therapies," added Kevin McKinnon, DEED temporary commissioner. "The new Nucleus facility in Rochester will generate and retain high-quality jobs in the state. We're excited to support this effort to help attract the scientific workforce of the future to Minnesota."

Exclusive Research